During the past decade, Midwest Clinical Research Center conducted 84 clinical trials. In the 10-year time frame, 84 clinical trials started and 67 clinical trials were completed, i.e. on average, 79.8% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 35 clinical trials were completed. i.e. 97.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Midwest Clinical Research Center" #1 sponsor was "Sunovion" with 12 trials, followed by "Pfizer" with 10 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 9 trials sponsored, "Shire" with 8 trials sponsored and "Janssen Research & Development, LLC" with 8 trials sponsored. Other sponsors include 82 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Midwest Clinical Research Center" #1 collaborator was "Otsuka America Pharmaceutical" with 2 trials as a collaborator, "Syneos Health" with 2 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "IQVIA Biotech" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Midwest Clinical Research Center" are "Major Depressive Disorder" (21 trials), "Schizophrenia" (19 trials), "Depressive Disorder, Major" (13 trials), "Binge Eating Disorder" (6 trials) and "Depression" (5 trials). Many other conditions were trialed in "Midwest Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Midwest Clinical Research Center" are "Drug" (123 trials), "Other" (14 trials), "Device" (4 trials), "Combination Product" (3 trials) and "Genetic" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (62 trials), "placebo" (10 trials), "Rapastinel" (6 trials), "ADT" (3 trials) and "Bupivacaine HCl" (3 trials). Other intervention names were less common.

The vast majority of trials in "Midwest Clinical Research Center" are 128 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Midwest Clinical Research Center". undefined are not yet recruiting, 16 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 102 completed trials in Midwest Clinical Research Center, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Midwest Clinical Research Center, 3 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 73 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 6 trials that are defined as “Not Applicable".